BioAtla, Inc. [Rocket]

Overview

BioAtla, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/03/2023	4	Williams Eddie (Director) has filed a Form 4 on BioAtla, Inc.
10/03/2023	4	GRAY MARY ANN (Director) has filed a Form 4 on BioAtla, Inc.
10/02/2023	4	SHORT JAY M PHD (CEO) has filed a Form 4 on BioAtla, Inc.
10/02/2023	4	WALDRON RICHARD A (CFO) has filed a Form 4 on BioAtla, Inc.
10/02/2023	4	Vasquez Christian (See Remarks) has filed a Form 4 on BioAtla, Inc.
10/02/2023	4	Smith Scott Andrew (Director) has filed a Form 4 on BioAtla, Inc.
10/02/2023	4	Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
Revenues	0.0	0.3	0.0	0.0	10.6
Revenue growth	-100.0%			-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.3	0.0	0.0	10.6
Gross margin		100.0%			100.0%
Selling, general and administrative	108.1	96.7	30.5	33.5
Research and development					26.3
General and administrative					12.6
EBIT	0.0	-96.4	0.0	0.0	-28.2
EBIT margin		-32130.0%			-265.7%
Pre-tax income	0.0	0.0	0.0	0.0	-29.0
Income taxes	0.0	0.0	0.0	0.0	0.0
Tax rate					0.0%
Net income	0.0	0.0	0.0	0.0	-29.0
Net margin		0.0%			-272.7%

Diluted EPS	$0.00	$0.00	$0.00
Shares outstanding (diluted)	38.9	34.6	8.4

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.